Back to Markets
GYGyre Therapeutics Inc

Gyre Therapeutics Inc

GYRE
Health CareBiotechnology: Pharmaceutical Preparations

$5.91

+0.1700 (+2.96%)

As of 05/29/26 EDT · USD

Compare
Low: $5.67Current: $5.91High: $9.42

Key Statistics

Open

$5.74

Day High

$5.98

Day Low

$5.74

Prev. Close

$5.74

VolumeShares traded today.

87.64K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$540.01M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-79.01

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$9.42

52W LowLowest price over the past 52 weeks.

$5.67

50D MAAverage closing price over the last 50 trading days.

$7.13

200D MAAverage closing price over the last 200 trading days.

$7.63

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

-4.4%

1M

-19.6%

6M

-23.4%

YTD

-13.2%

1Y

-34.8%

About

Bryan Johnson is an American entrepreneur, venture capitalist, writer and author. He is the founder and former CEO of Kernel, a company creating devices that monitor and record brain activity, and OS Fund, a venture capital firm that invests in early-stage science and technology companies.

Company Facts

SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade GYRE

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.